NHC 2023 GAAP EPS $4.34 vs $1.45; adjusted EPS $3.55; revenue up 5.1% to $1.14B

NATIONAL HEALTHCARE CORP

2023-FY EPS reported $4.34 revenue$1,141,544,000

Full-year GAAP net income $66.8M ($4.34 diluted EPS) vs $22.4M ($1.45) in 2022.
Adjusted net income $54.9M ($3.55 adjusted EPS) up 47% from $37.3M ($2.42) in 2022.
Net operating revenues and grant income $1.14B, up 5.1% YoY; same-facility revenue up 11.3%.
Q4 GAAP net income $28.4M ($1.83 EPS) vs $6.4M ($0.41) in Q4 2022; adjusted Q4 EPS $1.03 vs $0.72.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NATIONAL HEALTHCARE CORP reported the quarter ended December 31, 2023 results: net income $28,406,000, EPS $1.83.

Period: the quarter ended December 31, 2023
Net income: $28,406,000
EPS: $1.83
Result: reported results

Exact text from the filing

For the quarter ended December 31, 2023, the reported GAAP net income attributable to NHC was $28,406,000 compared to $6,353,000 for the same period in 2022.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NATIONAL HEALTHCARE CORP reported the year ended December 31, 2023 results: revenue $1,141,544,000, net income $66,798,000, EPS $4.34.

Period: the year ended December 31, 2023
Revenue: $1,141,544,000
Net income: $66,798,000
EPS: $4.34
Result: reported results

Exact text from the filing

announced today net operating revenues and grant income for the year ended December 31, 2023 totaled $1,141,544,000 compared to $1,085,738,000 for the year ended December 31, 2022, an increase of 5.1%.

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

NATIONAL HEALTHCARE CORP filing history →

Source: SEC EDGAR

accession 0001437749-24-004621

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.